Found: 204
Select item for more details and to access through your institution.
Genetics and molecular biology of chronic lymphocytic leukemia.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 482, n. 6, p. 1011, doi. 10.1007/s00428-023-03520-x
- By:
- Publication type:
- Article
1719. Incidence and Characterization of Invasive Fungal Infections (IFIs) in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib (IBR).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S630, doi. 10.1093/ofid/ofz360.1582
- By:
- Publication type:
- Article
2211. Impact of Early Fiberoptic Bronchoscopy on Microbiological Diagnostic Rate and Clinical Outcomes of Pneumonia in Acute Leukemia Patients.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S753, doi. 10.1093/ofid/ofz360.1889
- By:
- Publication type:
- Article
The TKI Era in Chronic Leukemias.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 12, p. 2201, doi. 10.3390/pharmaceutics13122201
- By:
- Publication type:
- Article
T-Cell Prolymphocytic Leukemia: A Single-Institution Experience.
- Published in:
- Clinical Lymphoma & Myeloma, 2005, v. 6, n. 3, p. 234
- By:
- Publication type:
- Article
Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5481, doi. 10.3390/ijms24065481
- By:
- Publication type:
- Article
Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia: Samples from Adults and the Children's Oncology Group.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5460, doi. 10.3390/ijms24065460
- By:
- Publication type:
- Article
Clinical and molecular characteristics and treatment patterns of adolescent and young adult patients with chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 1, p. 61, doi. 10.1111/bjh.17498
- By:
- Publication type:
- Article
The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 1, p. e1, doi. 10.1111/bjh.16117
- By:
- Publication type:
- Article
Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single‐agent ibrutinib in patients with chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 1, p. 184, doi. 10.1111/bjh.15791
- By:
- Publication type:
- Article
Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B‐cell receptor pathway inhibitor.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 961, doi. 10.1111/bjh.15666
- By:
- Publication type:
- Article
A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 3, p. 606, doi. 10.1111/bjh.15581
- By:
- Publication type:
- Article
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 4, p. 504, doi. 10.1111/bjh.15421
- By:
- Publication type:
- Article
A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B‐cell acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 3, p. 442, doi. 10.1111/bjh.14806
- By:
- Publication type:
- Article
Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observation.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 4, p. 597, doi. 10.1111/bjh.14398
- By:
- Publication type:
- Article
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 1, p. 33, doi. 10.1111/bjh.15018
- By:
- Publication type:
- Article
Chlorinated adenosine analogue induces AMPK and autophagy in chronic lymphocytic leukaemia cells during therapy.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 2, p. 266, doi. 10.1111/bjh.14859
- By:
- Publication type:
- Article
Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 4, p. 567, doi. 10.1111/bjh.14596
- By:
- Publication type:
- Article
Analysis of 2013 European LeukaemiaNet ( ELN) responses in chronic phase CML across four frontline TKI modalities and impact on clinical outcomes.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 1, p. 114, doi. 10.1111/bjh.13936
- By:
- Publication type:
- Article
Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 3, p. 392, doi. 10.1111/bjh.13834
- By:
- Publication type:
- Article
CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 726, doi. 10.1111/bjh.13659
- By:
- Publication type:
- Article
The addition of CD20 monoclonal antibodies to lenalidomide improves response rates and survival in relapsed/refractory patients with chronic lymphocytic leukaemia relative to lenalidomide monotherapy - the MD Anderson Cancer Center experience.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 2, p. 281, doi. 10.1111/bjh.13377
- By:
- Publication type:
- Article
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 1, p. 40, doi. 10.1111/bjh.13380
- By:
- Publication type:
- Article
Trisomy 12 is associated with an abbreviated redistribution lymphocytosis during treatment with the BTK inhibitor ibrutinib in patients with chronic lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 1, p. 125, doi. 10.1111/bjh.13269
- By:
- Publication type:
- Article
Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells.
- Published in:
- Molecular Cancer, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1476-4598-12-50
- By:
- Publication type:
- Article
Frontline combination of ponatinib and hyper‐CVAD in Philadelphia chromosome‐positive acute lymphoblastic leukemia: 80‐months follow‐up results.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 493, doi. 10.1002/ajh.26816
- By:
- Publication type:
- Article
TP53‐altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor‐based therapy: A retrospective analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1005, doi. 10.1002/ajh.26595
- By:
- Publication type:
- Article
Dismal outcomes of patients with relapsed/refractory Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukemia after failure of both inotuzumab ozogamicin and blinatumomab.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E201, doi. 10.1002/ajh.26526
- By:
- Publication type:
- Article
Non‐coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E100, doi. 10.1002/ajh.26457
- By:
- Publication type:
- Article
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. 241, doi. 10.1002/ajh.26047
- By:
- Publication type:
- Article
Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies.
- Published in:
- Drugs, 2019, v. 79, n. 12, p. 1287, doi. 10.1007/s40265-019-01163-4
- By:
- Publication type:
- Article
Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128151
- By:
- Publication type:
- Article
The PI3-Kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-Mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083830
- By:
- Publication type:
- Article
Generation of Functional CLL-Specific Cord Blood CTL Using CD40-Ligated CLL APC.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051390
- By:
- Publication type:
- Article
A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028277
- By:
- Publication type:
- Article
Immunologic monitoring in chronic lymphocytic leukemia.
- Published in:
- Current Oncology Reports, 2003, v. 5, n. 5, p. 419, doi. 10.1007/s11912-003-0029-3
- By:
- Publication type:
- Article
Recent Updates in Monitoring and Sequencing Treatment in Chronic Lymphocytic Leukemia.
- Published in:
- Oncology (08909091), 2023, v. 37, n. 3, p. 150
- By:
- Publication type:
- Article
Selection of a Nuclease-Resistant RNA Aptamer Targeting CD19.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5220, doi. 10.3390/cancers13205220
- By:
- Publication type:
- Article
Does FCR Have the Potential to Cure a Subgroup of Patients With Chronic Lymphocytic Leukemia?
- Published in:
- Clinical Advances in Hematology & Oncology, 2019, v. 17, n. 4, p. 214
- By:
- Publication type:
- Article
High serum thymidine kinase 1 level predicts poorer survival in patients with chronic lymphocytic leukemia.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Outcome of First Salvage Therapy in Patients With Chronic Lymphocytic Leukemia Relapsing After First-line Fludarabine, Cyclophosphamide, and Rituximab.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 6, p. E39, doi. 10.3816/CLM.2009.n.101
- By:
- Publication type:
- Article
Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 6, p. E36, doi. 10.3816/CLM.2009.n.098
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 331, doi. 10.1007/s10637-008-9129-0
- By:
- Publication type:
- Article
A prospective analysis of symptom burden for patients with chronic myeloid leukemia in chronic phase treated with frontline second‐ and third‐generation tyrosine kinase inhibitors.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 11, p. 5457, doi. 10.1002/cam4.1808
- By:
- Publication type:
- Article
Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.833714
- By:
- Publication type:
- Article
Monitoring and Managing BTK Inhibitor Treatment-Related Adverse Events in Clinical Practice.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.720704
- By:
- Publication type:
- Article
Acalabrutinib: A Selective Bruton Tyrosine Kinase Inhibitor for the Treatment of B-Cell Malignancies.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.668162
- By:
- Publication type:
- Article
Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL).
- Published in:
- Journal of Blood Medicine, 2010, v. 1, p. 115
- By:
- Publication type:
- Article
A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia.
- Published in:
- 2014
- By:
- Publication type:
- journal article